UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 138

Sortiert nach

eIF4E Phosphorylation in Prostate Cancer

Neoplasia (New York, N.Y.), 2018-06, Vol.20 (6), p.563-573

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-circadian aspects of BHLHE40 cellular function in cancer

Genes & cancer, 2020, Vol.11 (1-2), p.1-19

2020

Link zum Volltext

Verfügbarkeit prüfen

Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies

International journal of molecular sciences, 2023-07, Vol.24 (14), p.11395

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathologic Characterization of Prostatic Cancer in Dogs

Animals (Basel), 2024-02, Vol.14 (4), p.588

2024

Link zum Volltext

Verfügbarkeit prüfen

Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy

PloS one, 2015-08, Vol.10 (8), p.e0134346-e0134346

2015

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional-translational conflict: a novel exploitable tumor suppressive mechanism

Signal transduction and targeted therapy, 2023-09, Vol.8 (1), p.361-361, Article 361

2023

Link zum Volltext

Verfügbarkeit prüfen

Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells

Scientific reports, 2023-01, Vol.13 (1), p.1762-1762, Article 1762

2023

Link zum Volltext

Verfügbarkeit prüfen

Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer

Scientific reports, 2023-06, Vol.13 (1), p.9617-9617, Article 9617

2023

Link zum Volltext

Verfügbarkeit prüfen

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy

Biomedicines, 2020-10, Vol.8 (10), p.422

2020

Link zum Volltext

Verfügbarkeit prüfen

Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development

Biomedicines, 2023-08, Vol.11 (8), p.2215

2023

Link zum Volltext

Verfügbarkeit prüfen

Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators

International journal of molecular sciences, 2019-03, Vol.20 (6), p.1285

2019

Link zum Volltext

Verfügbarkeit prüfen

Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants

Biomedicines, 2023-04, Vol.11 (4), p.1100

2023

Link zum Volltext

Verfügbarkeit prüfen

Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice

International journal of molecular sciences, 2019-10, Vol.20 (20), p.4983

2019

Link zum Volltext

Verfügbarkeit prüfen

Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer

Cancer research (Chicago, Ill.), 2004-08, Vol.64 (15), p.5232-5236

2004

Link zum Volltext

Verfügbarkeit prüfen

Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation

Clinical cancer research, 2007-07, Vol.13 (13), p.3860-3867

2007

Link zum Volltext

Verfügbarkeit prüfen

Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans

Biomedicines, 2021-10, Vol.9 (10), p.1472

2021

Link zum Volltext

Verfügbarkeit prüfen

Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer

Translational oncology, 2019-07, Vol.12 (7), p.871-878

2019

Link zum Volltext

Verfügbarkeit prüfen

Celebrating the 80th anniversary of hormone ablation for prostate cancer

Endocrine-related cancer, 2021-08, Vol.28 (8), p.T1-T10

2021

Link zum Volltext

Verfügbarkeit prüfen

The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it

Endocrine-related cancer, 2013-12, Vol.20 (6), p.R341-R356

2013

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical Demonstration of Phospho-Akt in High Gleason Grade Prostate Cancer

Clinical cancer research, 2002-04, Vol.8 (4), p.1168-1171

2002

Link zum Volltext

Verfügbarkeit prüfen

Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs

Metabolites, 2022-02, Vol.12 (3), p.200

2022

Link zum Volltext

Verfügbarkeit prüfen

Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes

Communications medicine, 2022-09, Vol.2 (1), p.118-118, Article 118

2022

Link zum Volltext

Verfügbarkeit prüfen

WOMEN IN CANCER PROFILE: From physics to cancer biology and everywhere in between

Endocrine-related cancer, 2016-11, Vol.23 (11), p.P15-P21

Ghosh, Paramita M

2016

Link zum Volltext

Verfügbarkeit prüfen

Genistein Combined Polysaccharide (GCP) Can Inhibit Intracrine Androgen Synthesis in Prostate Cancer Cells

Biomedicines, 2020-08, Vol.8 (8), p.282

2020

Link zum Volltext

Verfügbarkeit prüfen

Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines

Endocrine-related cancer, 2010-12, Vol.17 (4), p.857-873

2010

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 138

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(119)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Englisch
(138)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

eIF4E Phosphorylation in Prostate Cancer

Non-circadian aspects of BHLHE40 cellular function in cancer

Pesticides and Bladder Cancer: Mechanisms Leading to Anti-Cancer Drug Chemoresistance and New Chemosensitization Strategies

Clinicopathologic Characterization of Prostatic Cancer in Dogs

Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy

Transcriptional-translational conflict: a novel exploitable tumor suppressive mechanism

Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells

Cisplatin-induced increase in heregulin 1 and its attenuation by the monoclonal ErbB3 antibody seribantumab in bladder cancer

The Androgen Receptor in Prostate Cancer: Effect of Structure, Ligands and Spliced Variants on Therapy

Beyond Prostate Cancer: An Androgen Receptor Splice Variant Expression in Multiple Malignancies, Non-Cancer Pathologies, and Development

Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators

Molecular Similarities and Differences between Canine Prostate Cancer and Human Prostate Cancer Variants

Methionine Adenosyltransferase 1a (MAT1A) Enhances Cell Survival During Chemotherapy Treatment and is Associated with Drug Resistance in Bladder Cancer PDX Mice

Phosphorylation of Akt (Ser473) is an excellent predictor of poor clinical outcome in prostate cancer

Determining Risk of Biochemical Recurrence in Prostate Cancer by Immunohistochemical Detection of PTEN Expression and Akt Activation

Comparative Cancer Cell Signaling in Muscle-Invasive Urothelial Carcinoma of the Bladder in Dogs and Humans

Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer

Celebrating the 80th anniversary of hormone ablation for prostate cancer

The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it

Immunohistochemical Demonstration of Phospho-Akt in High Gleason Grade Prostate Cancer

Untargeted Metabolomics Identify a Panel of Urinary Biomarkers for the Diagnosis of Urothelial Carcinoma of the Bladder, as Compared to Urolithiasis with or without Urinary Tract Infection in Dogs

Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomes

WOMEN IN CANCER PROFILE: From physics to cancer biology and everywhere in between

Genistein Combined Polysaccharide (GCP) Can Inhibit Intracrine Androgen Synthesis in Prostate Cancer Cells

Genome-wide analysis of androgen receptor binding and gene regulation in two CWR22-derived prostate cancer cell lines

Suchergebnisse filtern